Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6051–6100 of 18417
Concurrently, the Board of Directors of the Company appointed Greg Rubin as the Chairman of the Board and Interim CEO, effective immediately upon Mr. Rubinov's resignation.
On March 1, 2024, Edmond Cheng, the chief financial officer (“CFO”) of Cenntro Inc. (the “Company”), notified the Board of Directors of the Company (the “Board”) of his intention not to renew his employment agreement with the Company and his service as CFO to the Company ended March 1, 2024.
the Board appointed Edward Ye, the corporate controller of the Company to serve as the Company’s acting CFO with annual compensation of US$91,555 to fill the vacancy created by Mr. Cheng effective as of March 1, 2024.
On February 28, 2024, Nicholas H. Goodman was appointed chief executive officer of Oaktree Capital Group, LLC (the “Company”) by the board of directors of the Company (the “Board”), effective as of March 1, 2024.
Madhukar Bhalla, Chief Financial Officer and Secretary of Incannex Healthcare Inc. (the “Company”), recently notified the Company of his decision to resign from his positions effective as of February 28, 2024.
The Company’s Board of Directors has appointed Joseph Swan, the current Treasurer and Controller of the Company, as its Chief Financial Officer and Secretary effective as of February 29, 2024.
Effective March 4, 2024, the Board of Directors of the Company appointed Nelson W. Grist as Chief Executive Officer.
On March 4, 2024, the Board of Directors of the Company appointed Ernesto L. Flores as the Company’s CFO, succeeding Gabrielle Schuster.
received a resignation notice from Gabrielle Schuster resigning from her role as Chief Financial Officer
appointed Mr. Aharon Klein Chief Technology Officer and a cofounder of the company to serve as its Interim Chief Executive Officer
On 4 th March 2024, Eventiko Inc (the “Company”) announced the resignation of Mr Wei Zhong as President and Chief Executive Officer and a director of the Company.
Also on 4 th March 2024, the Company appointed Mr Yap Chin Liang as its President and Chief Executive Officer, and as a director of the Company with immediate effect.
the Board promoted Jason Vlacich, the Chief Accounting Officer of the Company, to the role of Chief Financial Officer and Chief Accounting Officer, effective as of January 23, 2024.
Luisa Puche tendered her resignation as Chief Financial Officer of Renovaro Inc. (the “Company”), effective as of March 21, 2024.
Shanoop Kothari, will become sole Chief Executive Officer and acting Chief Financial Officer
Frederick Brightbill, Chief Executive Officer and Chairman of the Board of Directors of MasterCraft Boat Holdings, Inc. (the “Company”) announced his retirement as Chief Executive Officer of the Company, effective March 18, 2024
the Company appointed Brad Nelson as Chief Executive Officer, effective March 18, 2024
Effective March 1, 2024, Kayla Hawkins, Executive Vice President, Reporting Manager of Wilson Bank & Trust (the “Bank”), was appointed the Chief Financial Officer of Wilson Bank Holding Company (the “Company”) and the Bank, replacing Lisa Pominski in that role in advance of Ms. Pominski’s expected, and previously announced, retirement from the Company and the Bank on March 31, 2024.
Ms. Pominski will continue to be compensated as an employee of the Company and the Bank through the last day that she is employed, which is expected to be March 31, 2024, at the rate that was in effect prior to her ceasing to serve as the Company’s Chief Financial Officer.
On March 1, 2024, the Board elected not to renew or extend the term of the Company’s employment agreement with Octávio Simões, the Chief Executive Officer of the Company, beyond the term ending on June 5, 2024.
Edward M. Weil, Jr., the Company’s other Co-Chief Executive Officer, will continue as the Company’s sole Chief Executive Officer.
Mr. Nelson also expects to retire and resign from his position as the Company’s President and Co-Chief Executive Officer, which will be effective on or around March 31, 2024
In the meantime, following Mr. Messenger’s departure, J. Scott Dixon, the Company’s current Assistant Chief Financial Officer, will assume the role of Interim Chief Financial Officer until a permanent successor is appointed.
On March 4, 2024, David L. Messenger, Chief Financial Officer of Century Communities, Inc. (the “Company”), notified the Company that he is stepping down effective March 22, 2024 after 10 years with the Company to pursue other opportunities.
Nicholas L. Swyka’s service as the Senior Vice President and Chief Financial Officer of the Company ended
On March 4, 2024, Christopher K. George, currently the Senior Vice President, Corporate Development, Investor Relations, & Sustainability of Select Water Solutions, Inc. (the “Company”), was appointed as Executive Vice President and Chief Financial Officer of the Company, effective immediately.
On February 28, 2024, the Board of Directors (the “Board”) of Cerence Inc. (the “Company”) appointed Daniel Tempesta as Chief Financial Officer (and, in such capacity, the “principal financial officer” and “principal accounting officer” of the Company), effective March 18, 2024.
On February 27, 2024, Scott E. Royer notified Vaccinex Inc. (the “Company”) of his decision to retire from his position as the Company’s Chief Financial Officer effective March 14, 2024.
effective upon Mr. Royer’s retirement on March 14, 2024, Jill Sanchez, age 52, will serve as the Company’s Interim Chief Financial Officer and as its Principal Financial Officer and Principal Accounting Officer.
Mr. Scott Adelson will become the Chief Executive Officer of the Company.
the board of directors of Pubco appointed the following officers: Tony Sage as Executive Chairman and Dietrich Wanke as Chief Executive Officer.
On March 4, 2024, Landmark Bancorp, Inc. (the “Company”) announced that it has appointed Abigail M. Wendel to serve as the President and Chief Executive Officer of the Company and Landmark National Bank, its wholly-owned bank subsidiary (the “Bank”), effective on the transition date, which is currently anticipated to be March 29, 2024 (the “Transition Date”), and will join their respective boards of directors.
Mr. Scheopner will retire as the President and Chief Executive Officer of the Company and the Bank, effective on the Transition Date.
On March 1, 2024, the appointment of Jolie Kahn, as Chief Financial Officer of Ocean Biomedical, Inc. (the “Company”) was confirmed.
Ms. Kahn replaces Gurinder Kalra who resigned effective January 30, 2024 to pursue other interests.
On March 1, 2024, Aren C. LeeKong informed Carlyle Secured Lending, Inc. (the “Company”) that he is resigning from the Board of Directors of the Company (the “Board”) and his positions as the President and Chief Executive Officer of the Company, in each case effective March 1, 2024, to pursue other opportunities.
On March 1, 2024, the Board appointed Justin Plouffe as a Class II Director of the Company and its President and Chief Executive Officer, effective immediately.
On March 4, 2024, NMI Holdings, Inc. (the “Company”) announced that Aurora Swithenbank has been appointed Executive Vice President and Chief Financial Officer, effective May 1, 2024.
On March 4, 2024, the Company announced that Ravi Mallela, the Company’s Executive Vice President and Chief Financial Officer, will be leaving the Company effective May 1, 2024.
On March 1, 2024 (the “Effective Date”), Kathleen Borthwick, the Company’s current Senior Vice President and Interim Chief Financial Officer was appointed to serve as Chief Financial Officer.
On March 1, 2024, the Board of Directors (the “Board” ) of NeuroBo Pharmaceuticals, Inc. (the “Company” ) appointed Mr. Marshall H. Woodworth, age 66, as the Company’s Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, effective as of March 1, 2024.
Joe Bardswich, age 79, Co-CEO & Director
Gary C. Evans, age 66, Co-CEO & Chairman of the Board
On March 1, 2024, the Board appointed Justin Plouffe as a Class II Director of the Company and its President and Chief Executive Officer, effective immediately.
On March 1, 2024, Aren C. LeeKong informed Carlyle Credit Solutions, Inc. (the “Company”) that he is resigning from the Board of Directors of the Company (the “Board”) and his positions as the President and Chief Executive Officer of the Company, in each case effective March 1, 2024, to pursue other opportunities.
On March 3, 2024, the board of directors of Nikola Corporation (the “Company”) appointed Thomas B. Okray to serve as the Company’s Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, effective March 4, 2024.
On March 1, 2024, Aren C. LeeKong informed Carlyle Secured Lending III (the “Company”) that he is resigning from the Board of Trustees of the Company (the “Board”) and his positions as the President and Chief Executive Officer of the Company, in each case effective March 1, 2024, to pursue other opportunities.
On March 1, 2024, the Board appointed Justin Plouffe as a Trustee of the Company and its President and Chief Executive Officer, effective immediately.
On February 28, 2024, Mr. Rob L. White was appointed Executive Vice President and Chief Financial Officer of the Company, with such appointment to become effective May 1, 2024.
On February 27, 2024, Dane E. Whitehead, Executive Vice President and Chief Financial Officer of Marathon Oil Corporation (“Marathon Oil” or the “Company”), informed the Company of his intention to retire from Marathon Oil effective July 1, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.